|
03-07-2022 |
Biologic dose escalation - Gastroenterology, rheumatology and dermatology
|
|
05-06-2022 |
Assessment of insulin pump systems for type 1 diabetes patients |
|
05-09-2022 |
Relevance of the prerequisite of the use of an immunosuppressant drug for the coverage of biologic agents (gastroenterology and dermatology) |
|
12-21-2023 |
Assessment of InterceptTM and MirasolTM Pathogen Reduction Technologies for the Treatment of Labile Blood Products in Quebec |
|
01-13-2025 |
Microinvasive Glaucoma Surgery (MIGS): HydrusMC Microstent for the Treatment of Mild to Moderate Glaucoma |
|
05-12-2025 |
Polymalformative syndromes nextgeneration sequencing (NGS) panel |
|
05-26-2025 |
Microinvasive surgical (MIGS) devices and procedures for the treatment of moderate to severe glaucoma |
